Home Contact Site Map Text Size What's New 13.03.2019 Santen and the International Glaucoma Association create unique ‘eye test challenge’ for World Glaucoma Week 2019 25.02.2019 Santen launches preservative-free multi-dose Cosopt® and Taflotan®/Saflutan®, providing personalised management for glaucoma patients in Europe World Map Santen, a global pharmaceutical company specialized in ophthalmology Read more... Choose Country: Country Austria (Santen SA) Belgium, the Netherlands & Luxembourg Bulgaria China (Santen Pharmaceutical (China) Co., Ltd.) Czech Republic Denmark Europe, Middle-East and Africa (EMEA) Finland (Santen Oy) France (Santen S.A.S.) Germany (Santen GmbH) Hungary Ireland (Santen UK Ltd.) Italy (Santen Italy s.r.l.) Japan (Headquarters) Korea (Santen Pharmaceutical Korea, Co., Ltd.) Latvia Lithuania Norway Poland Portugal (Santen Pharma. Spain S.L.) Romania Russia (Santen LLC) Slovakia Spain (Santen Pharma. Spain S.L.) Sweden (SantenPharma AB) Switzerland (Santen SA) United Kingdom (Santen UK Ltd.) United States (Advanced Vision Science, Inc.) United States (Santen Inc.) United States (InnFocus Inc.) Terms of Use Privacy Policy Cookies Policy Copyright © 2018 Santen Pharmaceutical Co., Ltd. All Rights Reserved.